Syrma SGS Q2 FY27 Revenue ₹19,995 Mn, PAT ₹1,242 Mn
Syrma SGS Technology announced its unaudited financial results for the quarter and half-year ended September 30, 2026. For Q2 FY27, the company reported a Total Revenue of ₹19,995 Mn, a 73% year-on-year increase, with EBITDA at ₹2,031 Mn and PAT at ₹1,242 Mn, up 87% YoY. For H1 FY27, Total Revenue stood at ₹36,032 Mn (up 71% YoY), EBITDA at ₹3,798 Mn (up 68% YoY), and PAT at ₹2,299 Mn (up 98% YoY). The company highlighted strong export revenue growth and operational improvements, including a reduction in working capital to 63 days and positive operating cash flow. Key strategic developments include the inauguration of a new Bengaluru facility for its joint venture and a new medical plastics facility for its subsidiary Syrma Johari MedTech.
Key Highlights
- Q2 FY27 Revenue surged 73% YoY to ₹19,995 Mn.
- Q2 FY27 PAT grew 87% YoY to ₹1,242 Mn.
- H1 FY27 PAT nearly doubled, up 98% YoY to ₹2,299 Mn.
- Exports revenue grew 91% YoY in Q2 FY27.
- New facilities inaugurated for JV and MedTech subsidiary.
Price Impact
More from SYRMA